AARD$1.22+1.67%
Aardvark Therapeutics, Inc.
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap:$26.7M
Float & O/S:
Inst Own:
DilutionScan read 24 of Aardvark Therapeutics, Inc.'s SEC filings and found 3 convertibles, 1 ATM program, 1 shelf registration and 1 S-1 registration on file for AARD. The latest dilution event on file is ATM sales on Jun 30, 2026. Analysis updated Oct 31, 2026.
